Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.

Identifieur interne : 004300 ( Ncbi/Merge ); précédent : 004299; suivant : 004301

A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.

Auteurs : Hemanta Kumar Nayak [Inde] ; Mradul Kumar Daga ; Sandeep Kumar Garg ; Nitin Kumar Sinha ; Rakshit Kumar ; Pankaj Kumar Mohanty ; Binay Kumar Pandey

Source :

RBID : pubmed:21519822

Descripteurs français

English descriptors

Abstract

Lymphatic filariasis is a major health problem in India with a large number of patients tending to be asymptomatic. In the Southeast and South Asian regions, Wuchereria bancrofti is the most prevalent parasite, causing filariasis in 99.4% of cases. While kidney involvement is a rare event in chronic filariasis, this case is unique because AA-type renal amyloidosis occurs in chronic W. bancrofti infection. We present here a unique case of lymphatic filariasis. The patient, a 25-year-old male who was previously diagnosed with right lower limb filarial lymphedema and had undergone lymphovenous anastomosis, was admitted for evaluation of persistent nephrotic-range proteinuria. Autoimmune markers in the form of anti-nuclear antibodies, anti-double-stranded DNA and anti-neutrophil cytoplasmic antibody were negative; C3 was normal. Urine analysis revealed inactive sediment with moderate proteinuria. Both serum and urine electrophoresis were negative for paraproteins and bone marrow aspirate and biopsy were normal. Evidence of active filarial infection was established on the basis of microfilariae in the peripheral smear and a positive W. bancrofti antigen test. Kidney biopsy revealed renal amyloidosis when stained with Congo red and anti-AA immunostain. The patient's proteinuria improved on conservative management with angiotensin-converting enzyme inhibitors and a course of antifilarial drugs. His proteinuria returned to <1 g/24 h with normalization of renal function and no significant proteinuria on periodic follow-up at 6-month and 1-year intervals. Repeat kidney biopsy after 1.5 years showed regression of amyloidosis. Repeat demonstration of filarial antigen and microfilariae in the peripheral smear were negative on multiple occasions during the follow-up period. Although various chronic infections can lead to secondary renal amyloidosis, this is the first case reported in world literature where secondary amyloidosis developed as a complication of chronic filarial infection due to W. bancrofti. This is probably also the first case reported in world literature where renal amyloidosis has an etiological association with W. bancrofti infection and where patient symptoms improved with antifilarial and antiproteinuric management.

DOI: 10.1007/s10157-011-0448-7
PubMed: 21519822

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:21519822

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.</title>
<author>
<name sortKey="Nayak, Hemanta Kumar" sort="Nayak, Hemanta Kumar" uniqKey="Nayak H" first="Hemanta Kumar" last="Nayak">Hemanta Kumar Nayak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lok Nayak Hospital, Maulana Azad Medical College, P.G Men's Hostel, Room no-96, Bahadurshah Zafar Marg, New Delhi 110002, India. drhemantnayak@gmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Lok Nayak Hospital, Maulana Azad Medical College, P.G Men's Hostel, Room no-96, Bahadurshah Zafar Marg, New Delhi 110002</wicri:regionArea>
<wicri:noRegion>New Delhi 110002</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Daga, Mradul Kumar" sort="Daga, Mradul Kumar" uniqKey="Daga M" first="Mradul Kumar" last="Daga">Mradul Kumar Daga</name>
</author>
<author>
<name sortKey="Garg, Sandeep Kumar" sort="Garg, Sandeep Kumar" uniqKey="Garg S" first="Sandeep Kumar" last="Garg">Sandeep Kumar Garg</name>
</author>
<author>
<name sortKey="Sinha, Nitin Kumar" sort="Sinha, Nitin Kumar" uniqKey="Sinha N" first="Nitin Kumar" last="Sinha">Nitin Kumar Sinha</name>
</author>
<author>
<name sortKey="Kumar, Rakshit" sort="Kumar, Rakshit" uniqKey="Kumar R" first="Rakshit" last="Kumar">Rakshit Kumar</name>
</author>
<author>
<name sortKey="Mohanty, Pankaj Kumar" sort="Mohanty, Pankaj Kumar" uniqKey="Mohanty P" first="Pankaj Kumar" last="Mohanty">Pankaj Kumar Mohanty</name>
</author>
<author>
<name sortKey="Pandey, Binay Kumar" sort="Pandey, Binay Kumar" uniqKey="Pandey B" first="Binay Kumar" last="Pandey">Binay Kumar Pandey</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21519822</idno>
<idno type="pmid">21519822</idno>
<idno type="doi">10.1007/s10157-011-0448-7</idno>
<idno type="wicri:Area/PubMed/Corpus">002654</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002654</idno>
<idno type="wicri:Area/PubMed/Curation">002654</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002654</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002654</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002654</idno>
<idno type="wicri:Area/Ncbi/Merge">004300</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.</title>
<author>
<name sortKey="Nayak, Hemanta Kumar" sort="Nayak, Hemanta Kumar" uniqKey="Nayak H" first="Hemanta Kumar" last="Nayak">Hemanta Kumar Nayak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lok Nayak Hospital, Maulana Azad Medical College, P.G Men's Hostel, Room no-96, Bahadurshah Zafar Marg, New Delhi 110002, India. drhemantnayak@gmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Lok Nayak Hospital, Maulana Azad Medical College, P.G Men's Hostel, Room no-96, Bahadurshah Zafar Marg, New Delhi 110002</wicri:regionArea>
<wicri:noRegion>New Delhi 110002</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Daga, Mradul Kumar" sort="Daga, Mradul Kumar" uniqKey="Daga M" first="Mradul Kumar" last="Daga">Mradul Kumar Daga</name>
</author>
<author>
<name sortKey="Garg, Sandeep Kumar" sort="Garg, Sandeep Kumar" uniqKey="Garg S" first="Sandeep Kumar" last="Garg">Sandeep Kumar Garg</name>
</author>
<author>
<name sortKey="Sinha, Nitin Kumar" sort="Sinha, Nitin Kumar" uniqKey="Sinha N" first="Nitin Kumar" last="Sinha">Nitin Kumar Sinha</name>
</author>
<author>
<name sortKey="Kumar, Rakshit" sort="Kumar, Rakshit" uniqKey="Kumar R" first="Rakshit" last="Kumar">Rakshit Kumar</name>
</author>
<author>
<name sortKey="Mohanty, Pankaj Kumar" sort="Mohanty, Pankaj Kumar" uniqKey="Mohanty P" first="Pankaj Kumar" last="Mohanty">Pankaj Kumar Mohanty</name>
</author>
<author>
<name sortKey="Pandey, Binay Kumar" sort="Pandey, Binay Kumar" uniqKey="Pandey B" first="Binay Kumar" last="Pandey">Binay Kumar Pandey</name>
</author>
</analytic>
<series>
<title level="j">Clinical and experimental nephrology</title>
<idno type="eISSN">1437-7799</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Amyloidosis (etiology)</term>
<term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term>
<term>Animals</term>
<term>Anthelmintics (therapeutic use)</term>
<term>Antigens, Helminth (analysis)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (complications)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (immunology)</term>
<term>Humans</term>
<term>Kidney Diseases (etiology)</term>
<term>Male</term>
<term>Wuchereria bancrofti (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Amyloïdose (étiologie)</term>
<term>Animaux</term>
<term>Antigènes d'helminthe (analyse)</term>
<term>Antihelminthiques (usage thérapeutique)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (immunologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique)</term>
<term>Maladies du rein (étiologie)</term>
<term>Mâle</term>
<term>Wuchereria bancrofti (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antigens, Helminth</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Angiotensin-Converting Enzyme Inhibitors</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Antigènes d'helminthe</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Amyloidosis</term>
<term>Kidney Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
<term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Amyloïdose</term>
<term>Maladies du rein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Animals</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Animaux</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphatic filariasis is a major health problem in India with a large number of patients tending to be asymptomatic. In the Southeast and South Asian regions, Wuchereria bancrofti is the most prevalent parasite, causing filariasis in 99.4% of cases. While kidney involvement is a rare event in chronic filariasis, this case is unique because AA-type renal amyloidosis occurs in chronic W. bancrofti infection. We present here a unique case of lymphatic filariasis. The patient, a 25-year-old male who was previously diagnosed with right lower limb filarial lymphedema and had undergone lymphovenous anastomosis, was admitted for evaluation of persistent nephrotic-range proteinuria. Autoimmune markers in the form of anti-nuclear antibodies, anti-double-stranded DNA and anti-neutrophil cytoplasmic antibody were negative; C3 was normal. Urine analysis revealed inactive sediment with moderate proteinuria. Both serum and urine electrophoresis were negative for paraproteins and bone marrow aspirate and biopsy were normal. Evidence of active filarial infection was established on the basis of microfilariae in the peripheral smear and a positive W. bancrofti antigen test. Kidney biopsy revealed renal amyloidosis when stained with Congo red and anti-AA immunostain. The patient's proteinuria improved on conservative management with angiotensin-converting enzyme inhibitors and a course of antifilarial drugs. His proteinuria returned to <1 g/24 h with normalization of renal function and no significant proteinuria on periodic follow-up at 6-month and 1-year intervals. Repeat kidney biopsy after 1.5 years showed regression of amyloidosis. Repeat demonstration of filarial antigen and microfilariae in the peripheral smear were negative on multiple occasions during the follow-up period. Although various chronic infections can lead to secondary renal amyloidosis, this is the first case reported in world literature where secondary amyloidosis developed as a complication of chronic filarial infection due to W. bancrofti. This is probably also the first case reported in world literature where renal amyloidosis has an etiological association with W. bancrofti infection and where patient symptoms improved with antifilarial and antiproteinuric management.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21519822</PMID>
<DateCreated>
<Year>2011</Year>
<Month>08</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>12</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1437-7799</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2011</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Clinical and experimental nephrology</Title>
<ISOAbbreviation>Clin. Exp. Nephrol.</ISOAbbreviation>
</Journal>
<ArticleTitle>A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>591-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10157-011-0448-7</ELocationID>
<Abstract>
<AbstractText>Lymphatic filariasis is a major health problem in India with a large number of patients tending to be asymptomatic. In the Southeast and South Asian regions, Wuchereria bancrofti is the most prevalent parasite, causing filariasis in 99.4% of cases. While kidney involvement is a rare event in chronic filariasis, this case is unique because AA-type renal amyloidosis occurs in chronic W. bancrofti infection. We present here a unique case of lymphatic filariasis. The patient, a 25-year-old male who was previously diagnosed with right lower limb filarial lymphedema and had undergone lymphovenous anastomosis, was admitted for evaluation of persistent nephrotic-range proteinuria. Autoimmune markers in the form of anti-nuclear antibodies, anti-double-stranded DNA and anti-neutrophil cytoplasmic antibody were negative; C3 was normal. Urine analysis revealed inactive sediment with moderate proteinuria. Both serum and urine electrophoresis were negative for paraproteins and bone marrow aspirate and biopsy were normal. Evidence of active filarial infection was established on the basis of microfilariae in the peripheral smear and a positive W. bancrofti antigen test. Kidney biopsy revealed renal amyloidosis when stained with Congo red and anti-AA immunostain. The patient's proteinuria improved on conservative management with angiotensin-converting enzyme inhibitors and a course of antifilarial drugs. His proteinuria returned to <1 g/24 h with normalization of renal function and no significant proteinuria on periodic follow-up at 6-month and 1-year intervals. Repeat kidney biopsy after 1.5 years showed regression of amyloidosis. Repeat demonstration of filarial antigen and microfilariae in the peripheral smear were negative on multiple occasions during the follow-up period. Although various chronic infections can lead to secondary renal amyloidosis, this is the first case reported in world literature where secondary amyloidosis developed as a complication of chronic filarial infection due to W. bancrofti. This is probably also the first case reported in world literature where renal amyloidosis has an etiological association with W. bancrofti infection and where patient symptoms improved with antifilarial and antiproteinuric management.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nayak</LastName>
<ForeName>Hemanta Kumar</ForeName>
<Initials>HK</Initials>
<AffiliationInfo>
<Affiliation>Lok Nayak Hospital, Maulana Azad Medical College, P.G Men's Hostel, Room no-96, Bahadurshah Zafar Marg, New Delhi 110002, India. drhemantnayak@gmail.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Daga</LastName>
<ForeName>Mradul Kumar</ForeName>
<Initials>MK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Sandeep kumar</ForeName>
<Initials>Sk</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sinha</LastName>
<ForeName>Nitin kumar</ForeName>
<Initials>Nk</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Rakshit</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mohanty</LastName>
<ForeName>Pankaj Kumar</ForeName>
<Initials>PK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pandey</LastName>
<ForeName>Binay Kumar</ForeName>
<Initials>BK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>04</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Clin Exp Nephrol</MedlineTA>
<NlmUniqueID>9709923</NlmUniqueID>
<ISSNLinking>1342-1751</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C045193">Wuchereria antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>12</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>03</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>4</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>4</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21519822</ArticleId>
<ArticleId IdType="doi">10.1007/s10157-011-0448-7</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Daga, Mradul Kumar" sort="Daga, Mradul Kumar" uniqKey="Daga M" first="Mradul Kumar" last="Daga">Mradul Kumar Daga</name>
<name sortKey="Garg, Sandeep Kumar" sort="Garg, Sandeep Kumar" uniqKey="Garg S" first="Sandeep Kumar" last="Garg">Sandeep Kumar Garg</name>
<name sortKey="Kumar, Rakshit" sort="Kumar, Rakshit" uniqKey="Kumar R" first="Rakshit" last="Kumar">Rakshit Kumar</name>
<name sortKey="Mohanty, Pankaj Kumar" sort="Mohanty, Pankaj Kumar" uniqKey="Mohanty P" first="Pankaj Kumar" last="Mohanty">Pankaj Kumar Mohanty</name>
<name sortKey="Pandey, Binay Kumar" sort="Pandey, Binay Kumar" uniqKey="Pandey B" first="Binay Kumar" last="Pandey">Binay Kumar Pandey</name>
<name sortKey="Sinha, Nitin Kumar" sort="Sinha, Nitin Kumar" uniqKey="Sinha N" first="Nitin Kumar" last="Sinha">Nitin Kumar Sinha</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Nayak, Hemanta Kumar" sort="Nayak, Hemanta Kumar" uniqKey="Nayak H" first="Hemanta Kumar" last="Nayak">Hemanta Kumar Nayak</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004300 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004300 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:21519822
   |texte=   A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:21519822" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024